VN1R81P

Across TCGA pan-cancer cohorts, VN1R81P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated VN1R81P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher VN1R81P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VN1R81P expression acts as an unfavorable survival marker, although some lineages such as LUAD and COAD show a favorable association.

MESO, UVM, and LUAD are the cancer types where VN1R81P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	All	0.275	0.469	.011	55	view →
UVM	DFS	Tertile	III,IV	0.272	0.848	.003	38	view →
LUAD	OS	Quartile	II,III,IV	0.588	0.240	.005	34	view →
COAD	DFS	Median	II,III,IV	0.711	0.344	<.001	33	view →
ACC	DFS	Tertile	II,III,IV	0.077	0.638	.002	31	view →
UCS	DFS	Median	IV	0.885	0.440	.015	30	view →
LGG	DFS	Tertile	All	0.634	0.875	<.001	29	view →
CHOL	DFS	Quartile	II,III,IV	0.122	0.741	.024	16	view →
HNSC	OS	Quartile	III,IV	0.394	0.687	.005	15	view →
READ	OS	Median	II,III,IV	0.827	0.442	.012	14	view →
THYM	OS	Tertile	All	1.000	0.756	.009	12	view →
LIHC	DFS	Median	All	0.320	0.509	.007	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

VN1R81P–MESO (DFS)

Open the MESO breakdown →